Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT05875428 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.